Literature DB >> 7479067

The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins.

W W Zhang1, H Charest, G Matlashewski.   

Abstract

We have investigated the use of Leishmania cells as a novel eukaryotic expression system for the production of recombinant protein. These cells are easy to maintain, requiring no CO2 incubator or shaker, and can be grown in standard tissue culture media. Leishmania cells can be readily transfected with plasmid DNA by electroporation and transformants selected with antibiotic resistance. Recent studies have shown that it is possible to express foreign genes in Leishmania for the purpose of understanding the biology of this protozoan cell. In the present study we report the use of this system as a means of producing a biologically functional human p53 protein. The conformation of the p53 protein is critical for its ability to bind specific DNA sequences. It is demonstrated that Leishmania-synthesized human p53 is phosphorylated and can bind specifically to its enhancer DNA sequence. These data demonstrate that Leishmania may represent a simple eukaryotic expression system for the production of biologically active recombinant proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479067      PMCID: PMC307345          DOI: 10.1093/nar/23.20.4073

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

Authors:  L Banks; G Matlashewski; L Crawford
Journal:  Eur J Biochem       Date:  1986-09-15

Review 2.  Trans splicing of nuclear pre-mRNAs.

Authors:  N Agabian
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

Review 3.  The molecular biology of the Kinetoplastidae.

Authors:  C E Clayton
Journal:  Genet Eng       Date:  1988

4.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

Review 5.  Leishmania and the macrophage: a marriage of inconvenience.

Authors:  D G Russell; P Talamas-Rohana
Journal:  Immunol Today       Date:  1989-10

6.  DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6.

Authors:  Z Gu; D Pim; S Labrecque; L Banks; G Matlashewski
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

7.  Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.

Authors:  H Charest; G Matlashewski
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  Analysis of human p53 proteins and mRNA levels in normal and transformed cells.

Authors:  G Matlashewski; L Banks; D Pim; L Crawford
Journal:  Eur J Biochem       Date:  1986-02-03

Review 9.  Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage.

Authors:  L S Cox; D P Lane
Journal:  Bioessays       Date:  1995-06       Impact factor: 4.345

10.  Stable expression of the bacterial neor gene in Leishmania enriettii.

Authors:  A Laban; J F Tobin; M A Curotto de Lafaille; D F Wirth
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

View more
  14 in total

1.  Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Authors:  M Thomas; A Kalita; S Labrecque; D Pim; L Banks; G Matlashewski
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2.

Authors:  W W Zhang; G Matlashewski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Purification and crystallization of human Cu/Zn superoxide dismutase recombinantly produced in the protozoan Leishmania tarentolae.

Authors:  Emerich Mihai Gazdag; Ion Cristian Cirstea; Reinhard Breitling; Julius Lukes; Wulf Blankenfeldt; Kirill Alexandrov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-27

4.  Secreted recombinant P53 protein from Pichia pastoris is a useful antigen for detection of serum p53: autoantibody in patients with advanced colorectal adenocarcinoma.

Authors:  Salma Abdelmoula-Souissi; Nourane Zouari; Imen Miladi-Abdenadher; Ouhoud Yaich-Kolsi; Ines Ayadi-Masmoudi; Abdelmajid Khabir; Hatem Masmoudi; Mounir Frikha; Raja Mokdad-Gargouri
Journal:  Mol Biol Rep       Date:  2013-03-26       Impact factor: 2.316

5.  Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani.

Authors:  Wen-Wei Zhang; Laura-Isobel McCall; Greg Matlashewski
Journal:  Eukaryot Cell       Date:  2012-11-02

6.  CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

7.  Immunogenicity and Efficacy of Live L. tarentolae Expressing KMP11-NTGP96-GFP Fusion as a Vaccine Candidate against Experimental Visceral Leishmaniasis Caused by L. infantum.

Authors:  Vahid Nasiri; Abdolhossein Dalimi; Fatemeh Ghaffarifar; Azam Bolhassani
Journal:  Iran J Parasitol       Date:  2016 Apr-Jun       Impact factor: 1.012

8.  Cloning and Expression of Leishmania infantum LPG3 Gene by the Lizard Leishmania Expression System.

Authors:  Leila Pirdel; Ahmad Zavaran Hosseini; Bahram Kazemi; Manoochehr Rasouli; Mojgan Bandehpour; Sara Soudi
Journal:  Avicenna J Med Biotechnol       Date:  2012-10

9.  A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania.

Authors:  Wen-Wei Zhang; Christopher S Peacock; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2008-06-11

10.  Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management.

Authors:  Abul Hasan Sardar; Armando Jardim; Ayan Kumar Ghosh; Abhishek Mandal; Sushmita Das; Savita Saini; Kumar Abhishek; Ruby Singh; Sudha Verma; Ajay Kumar; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.